FDA Inspection 1192289 — Elyse S. Rafal, M.D.
The FDA completed an inspection of Elyse S. Rafal, M.D. on November 17, 2022 in Stony Brook, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 17, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stony Brook, NY (United States)
Additional Details
Clinical Investigator (CI)